Skip to main navigation Skip to search Skip to main content

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

  • Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group
  • University of Cambridge
  • Innsbruck Medical University
  • Medical University of South Carolina
  • Australian National University
  • University Forvie Site
  • Norwegian Institute of Public Health
  • National Institute of Public Health and the Environment
  • Utrecht University
  • Chiba Prefectural Institute of Public Health
  • University of Tromsø – The Arctic University of Norway
  • University of Oxford
  • The University of Sydney
  • Johns Hopkins University
  • National Institute for Health and Welfare
  • University of Copenhagen
  • University of Western Australia
  • Fiona Stanley Hospital
  • Harry Perkins Institute of Medical Research
  • London School of Hygiene and Tropical Medicine
  • Lund University
  • University of Pittsburgh
  • University Paris-Sud
  • University College London
  • Technical University of Munich
  • Ulm University
  • University of Padua
  • MRC Lifecourse Epidemiology Unit
  • German Cancer Research Center
  • Erasmus University Rotterdam
  • Umeå University
  • Cardiff University
  • Hospital Universitario 12 de Octubre
  • University of Greifswald
  • Aarhus University
  • German Institute of Human Nutrition Potsdam-Rehbruecke
  • University of New South Wales
  • Helenic Health Foundation
  • National and Kapodistrian University of Athens
  • Harvard University
  • University of Hawai'i at Mānoa
  • Navarra Medical Research Institute
  • Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)

Research output: Contribution to journalArticlepeer-review

1135 Scopus citations

Abstract

Background: Low-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular disease. Methods: We did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose–response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12·5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5·6 years [5th–95th percentile 1·04–13·5]) from 71 011 participants from 37 studies. Findings: In the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5·4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week. Alcohol consumption was roughly linearly associated with a higher risk of stroke (HR per 100 g per week higher consumption 1·14, 95% CI, 1·10–1·17), coronary disease excluding myocardial infarction (1·06, 1·00–1·11), heart failure (1·09, 1·03–1·15), fatal hypertensive disease (1·24, 1·15–1·33); and fatal aortic aneurysm (1·15, 1·03–1·28). By contrast, increased alcohol consumption was log-linearly associated with a lower risk of myocardial infarction (HR 0·94, 0·91–0·97). In comparison to those who reported drinking >0–≤100 g per week, those who reported drinking >100–≤200 g per week, >200–≤350 g per week, or >350 g per week had lower life expectancy at age 40 years of approximately 6 months, 1–2 years, or 4–5 years, respectively. Interpretation: In current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk. These data support limits for alcohol consumption that are lower than those recommended in most current guidelines. Funding: UK Medical Research Council, British Heart Foundation, National Institute for Health Research, European Union Framework 7, and European Research Council.

Original languageEnglish
Pages (from-to)1513-1523
Number of pages11
JournalThe Lancet
Volume391
Issue number10129
DOIs
StatePublished - Apr 14 2018

Fingerprint

Dive into the research topics of 'Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies'. Together they form a unique fingerprint.

Cite this